The global smart insulin pens market is expected to grow from $75.8 million in 2019 and to $77 million in 2020 at a growth rate of 1.6%. The slow growth is due to disruption in supply chains and restrictions on trade of medical products across countries owing to the COVID-19 outbreak. The market is then expected to grow and reach $98.4 million in 2023 at CAGR of 8.51%.
Read More @ https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-market-global-report-2020-30-covid-19-growth-and-change